Digostics, a UK-based diabetes home-testing provider, who graduated from our NHS Market Access Accelerator programme in 2022 have partnered with Medway NHS Foundation Trust to transform local gestational diabetes screening, by offering world-first home oral glucose tolerance testing (OGTT) technology to all at-risk women.
A global expert panel has recently announced that the condition hitherto known as polycystic ovary syndrome (PCOS) will officially undergo a name change to polyendocrine metabolic ovarian syndrome (PMOS).
Previously, doctors would diagnose the condition formerly known as PCOS based…
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital.
The raise was also backed by existing investors Alphabet and GV (Google Ventures) and new investors MGX, Temasek,…
Attendees
Sponsors and Exhibitors
Contact us